4.6 Review

Hepatocellular carcinoma:: surgical indications and results

期刊

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
卷 47, 期 1, 页码 13-27

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S1040-8428(02)00213-5

关键词

hepatocellular carcinoma; resection; liver surgery; review; primary liver tumours; treatment; outcome; recurrence

向作者/读者索取更多资源

Hepatocellular carcinoma (HCC) is a tumour of increasing incidence that usually arises in cirrhotic liver. Untreated, the prognosis is grim and the only curative treatment is surgical resection. The practical application of segmental surgery to the liver together with the use of ultrasound and other imaging techniques, patient selection criteria and improvements in perioperative technique and postoperative care have contributed to better results in hepatic surgery. Today, less than 10% mortality for resection of cirrhotic livers, with up to 50% 5-year survival rates are to be expected. However, the limits of resection for cure: intrahepatic recurrence makes stringent follow-up necessary. In this way the available modalities of treatment can be applied so as to improve survival. Herein, a current state-of-the-art of surgical indications and results for HCC is given. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据